尖吻蝮蛇血凝酶临床应用合理性研究  

Revaluating the Rationality of Haemocoagulase Agkistrodon in Clinical Use

作　　者：张富东[1] 朱敏凤 陈曦[1] 胡利群 ZHANG Fu-dong;ZHU Min-feng;CHEN Xi;HU Li-qun(Leshan Vocational&Technical College,Leshan 614000,China;Leshan Food and Drug Testing Center,Leshan 614000,China;Affiliated Hospital of Leshan Vocational and Technical College,Leshan 614000,China)

机构地区：[1]乐山职业技术学院,四川乐山614000 [2]乐山市食品药品检验检测中心,四川乐山614000 [3]乐山职业技术学院附属医院,四川乐山614000

出　　处：《海峡药学》2020年第12期97-99,共3页Strait Pharmaceutical Journal

基　　金：乐山市科技局软科学项目(编号18JRK005);乐山职业技术学院教改项目(编号JG2018019)。

摘　　要：目的调查本院尖吻蝮蛇血凝酶临床应用情况,为临床合理用药提供依据。方法抽取本院2019年1~6月使用尖吻蝮蛇血凝的住院病历共963份,填写点评处方登记表,评价用药合理性。结果用药不合理病历共356份,占总用药病例比例为36.97%,不合理用药情况有:适应证不适宜、用法用量不适宜等。结论本院尖吻蝮蛇血凝不合理用药现象多见,应针对不合理用药原因采取干预措施,使临床用药合理。OBJECTIVE To investigate the clinical application of Haemocoagulase Agkistrodon and promote its reasonable application.METHODS Selected 963 in-patientmedical records application of Haemocoagulase Agkistrodon in affiliated hospital from January 2019 to June 2019,filled in the comment form and evaluated the application of Haemocoagulase.RESULTS A total of 356 applications of Haemocoagulase Agkistrodon were irrational,the irrational use rate was 36.97%.There were many kinds of irrational Haemocoagulase Agkistrodon use,such as no indications,usage error.CONCLUSION The irrational Haemocoagulase Agkistrodon use in our hospital was serious,pharmaceutical intervention could be taken to promote that.

关 键 词：尖吻蝮蛇血凝酶 不合理用药 药学干预 

分 类 号：R969.4[医药卫生—药理学]